KCNT1 and autosomal dominant nocturnal frontal lobe epilepsy: Similarly, an observational study of 43 patients to evaluate the treatment responsiveness of patients with KCNT1-related epilepsy reported that quinidine was not utilized in any patients with an ADNFLE phenotype, whereas quinidine treatment was attempted in 17 patients with an EIMFS phenotype.